Vasoconstrictors in combination with proton pump inhibitors as an initial treatment of acute upper gastrointestinal bleeding in liver cirrhosis: is it evidence based?
作者信息
Gao Fan, Méndez-Sánchez Nahum, Qi Xingshun
机构信息
Medical Department, No. 202 Hospital of Chinese PLA, Shenyang 110003, China.
Liver Cirrhosis Group, Department of Gastroenterology, General Hospital of Shenyang Military Area, Shenyang 110840, China.
出版信息
Ann Transl Med. 2018 Aug;6(16):327. doi: 10.21037/atm.2018.08.07.
Abstract
摘要
相似文献
1
Vasoconstrictors in combination with proton pump inhibitors as an initial treatment of acute upper gastrointestinal bleeding in liver cirrhosis: is it evidence based?血管收缩剂联合质子泵抑制剂作为肝硬化急性上消化道出血的初始治疗：是否有循证依据？
Ann Transl Med. 2018 Aug;6(16):327. doi: 10.21037/atm.2018.08.07.
2
Should Vasoconstrictors be Considered in a Cirrhotic Patient with Acute Non-variceal Upper Gastrointestinal Bleeding?肝硬化急性非静脉曲张性上消化道出血患者是否应考虑使用血管收缩剂？
J Transl Int Med. 2017 Dec 29;5(4):240-244. doi: 10.1515/jtim-2017-0040. eCollection 2017 Dec.
3
Outcome of Conservative Therapy in Coronavirus disease-2019 Patients Presenting With Gastrointestinal Bleeding.2019冠状病毒病合并胃肠道出血患者的保守治疗结果
J Clin Exp Hepatol. 2021 May-Jun;11(3):327-333. doi: 10.1016/j.jceh.2020.09.007. Epub 2020 Oct 3.
4
Proton pump inhibitors versus histamine 2 receptor antagonists for stress ulcer prophylaxis in critically ill patients: a systematic review and meta-analysis.质子泵抑制剂与组胺 2 受体拮抗剂用于危重症患者应激性溃疡预防的比较：系统评价和荟萃分析。
Crit Care Med. 2013 Mar;41(3):693-705. doi: 10.1097/CCM.0b013e3182758734.
5
Interventions for preventing upper gastrointestinal bleeding in people admitted to intensive care units.重症监护病房患者上消化道出血的预防干预措施。
Cochrane Database Syst Rev. 2018 Jun 4;6(6):CD008687. doi: 10.1002/14651858.CD008687.pub2.
6
Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.质子泵抑制剂在复杂性溃疡疾病和上消化道出血中的应用。
Am J Health Syst Pharm. 1999 Dec 1;56(23 Suppl 4):S5-11. doi: 10.1093/ajhp/56.suppl_4.S5.
7
Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.新生儿上消化道出血的预防和治疗的药理学干预措施。
Cochrane Database Syst Rev. 2019 Jul 2;7(7):CD011785. doi: 10.1002/14651858.CD011785.pub2.
8
Cost-effectiveness in Canada of intravenous proton pump inhibitors for all patients presenting with acute upper gastrointestinal bleeding.加拿大针对所有急性上消化道出血患者静脉注射质子泵抑制剂的成本效益分析
Aliment Pharmacol Ther. 2003 Jan;17(2):225-33. doi: 10.1046/j.1365-2036.2003.01412.x.
9
Proton pump inhibitors for upper gastrointestinal bleeding.质子泵抑制剂治疗上消化道出血。
Best Pract Res Clin Gastroenterol. 2019 Oct-Dec;42-43:101609. doi: 10.1016/j.bpg.2019.04.002. Epub 2019 Apr 17.
10
Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis.质子泵抑制剂与肝硬化住院期间肝性脑病风险的关联
United European Gastroenterol J. 2018 Oct;6(8):1179-1187. doi: 10.1177/2050640618773564. Epub 2018 Apr 23.
本文引用的文献
1
Association of proton pump inhibitors with the risk of hepatic encephalopathy during hospitalization for liver cirrhosis.质子泵抑制剂与肝硬化住院期间肝性脑病风险的关联
United European Gastroenterol J. 2018 Oct;6(8):1179-1187. doi: 10.1177/2050640618773564. Epub 2018 Apr 23.
2
Should Vasoconstrictors be Considered in a Cirrhotic Patient with Acute Non-variceal Upper Gastrointestinal Bleeding?肝硬化急性非静脉曲张性上消化道出血患者是否应考虑使用血管收缩剂？
J Transl Int Med. 2017 Dec 29;5(4):240-244. doi: 10.1515/jtim-2017-0040. eCollection 2017 Dec.
3
Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies.使用当前一线治疗方法时，肝硬化合并急性消化性溃疡出血患者的生存率与静脉曲张出血患者的生存率比较。
Hepatology. 2018 Apr;67(4):1458-1471. doi: 10.1002/hep.29370. Epub 2018 Feb 18.
4
Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases.肝硬化门静脉高压出血：风险分层、诊断及管理：美国肝病研究协会2016年实践指南
Hepatology. 2017 Jan;65(1):310-335. doi: 10.1002/hep.28906. Epub 2016 Dec 1.
5
Proton pump inhibitors as a risk factor for hepatic encephalopathy and spontaneous bacterial peritonitis in patients with cirrhosis with ascites.质子泵抑制剂作为肝硬化伴腹水患者肝性脑病和自发性细菌性腹膜炎的危险因素。
Hepatology. 2016 Oct;64(4):1265-72. doi: 10.1002/hep.28737. Epub 2016 Aug 24.
6
Expanding consensus in portal hypertension: Report of the Baveno VI Consensus Workshop: Stratifying risk and individualizing care for portal hypertension.门静脉高压领域共识的拓展：巴韦诺VI共识研讨会报告：门静脉高压风险分层与个体化治疗
J Hepatol. 2015 Sep;63(3):743-52. doi: 10.1016/j.jhep.2015.05.022. Epub 2015 Jun 3.
7
U.K. guidelines on the management of variceal haemorrhage in cirrhotic patients.英国肝硬化患者静脉曲张出血管理指南。
Gut. 2015 Nov;64(11):1680-704. doi: 10.1136/gutjnl-2015-309262. Epub 2015 Apr 17.
8
Management of patients with ulcer bleeding.溃疡出血患者的处理。
Am J Gastroenterol. 2012 Mar;107(3):345-60; quiz 361. doi: 10.1038/ajg.2011.480. Epub 2012 Feb 7.
9
Asia-Pacific Working Group consensus on non-variceal upper gastrointestinal bleeding.亚太地区非静脉曲张性上消化道出血工作组共识。
Gut. 2011 Sep;60(9):1170-7. doi: 10.1136/gut.2010.230292. Epub 2011 Apr 6.
10
Proton pump inhibitors and risk for recurrent Clostridium difficile infection.质子泵抑制剂与艰难梭菌反复感染风险
Arch Intern Med. 2010 May 10;170(9):772-8. doi: 10.1001/archinternmed.2010.73.
Zotero 插件